C07K 16/1242
From pasteurellaceae
Official title: {from Pasteurellaceae (F), e.g. Haemophilus influenza}
C07K16/1242 (From pasteurellaceae) appears on 105 US grants and 118 published applications in this corpus.
Search patents in C07K- Granted patents
- 105
- Published applications
- 118
- Assignees
- 68
- Inventors
- 150
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 1 |
| 2003 | 2 | 3 |
| 2004 | 2 | 10 |
| 2005 | 1 | 6 |
| 2006 | 2 | 2 |
| 2007 | 4 | 3 |
| 2008 | 2 | 5 |
| 2009 | 4 | 4 |
| 2010 | 7 | 6 |
| 2011 | 2 | 6 |
| 2012 | 5 | 3 |
| 2013 | 1 | 4 |
| 2014 | 3 | 7 |
| 2015 | 3 | 8 |
| 2016 | 1 | 7 |
| 2017 | 5 | 3 |
| 2018 | 2 | 4 |
| 2019 | 2 | 5 |
| 2020 | 3 | 5 |
| 2021 | 4 | 3 |
| 2022 | 4 | 7 |
| 2023 | 5 | 6 |
| 2024 | 3 | 6 |
| 2025 | 6 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the treatment of immunodeficiency18 Nov 2025US 12,473,351 B2Adma Biomanufacturing, LLC
- Compositions and methods for using bispecific antibodies to bind complement and a target antigen4 Nov 2025US 12,459,991 B2Regeneron Pharmaceuticals, Inc.
- DNABII vaccines and antibodies with enhanced activity23 Sep 2025US 12,419,944 B2Research Institute At Nationwide Children's Hospital
- Peptides and antibodies for the removal of biofilms4 Mar 2025US 12,239,763 B2Research Institute At Nationwide Children's Hospital
- Proteins and immunizing compositions containing Pasteurella proteins and methods of use25 Feb 2025US 12,233,120 B2Vaxxinova US, Inc.
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Methods of analyzing recombinant polyclonal proteins3 Sep 2026US 2026/0259221 A1GigaGen, Inc.
- Compositions and methods for using bispecific antibodies to bind complement and a target antigen2 Apr 2026US 2026/0092102 A1Regeneron Pharmaceuticals, Inc.
- Proteins and immunizing compositions containing pasteurella proteins and methods of use14 Aug 2025US 2025/0255950 A1Vaxxinova US, Inc.
- Compositions and methods for using bispecific antibodies to bind complement and a target antigen1 Aug 2024US 2024/0254208 A2Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Intraoral administration device and system68US 5,993,413 A1999
- Synthetic chimeric fimbrin peptides38US 5,843,464 AThe Ohio State University · 1998
- Vaccine against Pasteurella35US 5,587,166 ABritish Technology Group Limited · 1996
- Vaccines for nontypable haemophilus influenzae34US 5,955,580 APraxis Biologies, Inc. · 1999
- Haemophilus influenzae peptides and proteins33US 5,110,908 APraxis Biologics, Inc. · 1992